Life Science Investor Mandates
(Aug. 9 - Aug. 15
)
|
|
|
|
|
Invests $10-50M Into Medical Device, Data and Health Monitoring Opportunities
|
|
Invests Up to $10M in Therapeutics, Diagnostics, Life Science Tools with Focus on Genomics Applications
|
|
Seeks to In-License Novel Therapeutic Assets and Platforms in Orphan/Rare Disease Indications
|
|
Invests Up to $10M in Data/Software-Driven Medical Devices and Digital Health Technologies
|
|
|
 With 3 weeks left until RESI Boston on Thursday, September 6th, we are happy to announce the top finalists who were accepted into the Innovation Challenge. The Innovation Challenge provides a unique opportunity to showcase promising technologies to investors, strategic partners, and more, beyond one-on-one partnering meetings. As usual, the Innovation Challenge features a diverse pool of start-ups in key sectors of the life sciences & healthcare space including therapeutics, medical devices, diagnostics, and digital health.
All RESI attendees will be provided with a generous amount of "RESI Cash" that people could use to "invest" in the Innovation Challenge companies of their choice. We encourage all attendees to stop by the exhibition hall to see what these Innovators have in store for the 800+ delegates we are anticipating for this conference...
|
 |
|
|
 |
|
|
By
Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series
 The First Coast Innovator's Gathering is a new component of the Redefining Early Stage Investments (RESI) Conference Series which was requested by the investors and strategic channel partners who routinely attend RESI. Many of these partners wanted LSN to bring the "earliest stage" companies so that they can identify them and get them on their radar screens in order to start a dialogue that can result in a future partnership. The First Coast Innovator's Gathering focuses on tech hubs and companies from the First Coast of life sciences: DC, MD, PA, NJ, NY, RI, CT, and MA. Dozens of tech hubs will be attending RESI to take a spot in the exhibit hall and showcase the new technologies being developed at their institution or facility. This fall, RESI will expand to include the earliest stage companies from the discovery stage through venture stage: companies seeking grants, seed, angel, series A, and series B funding.
This RESI event offers exhibit tables to the incubators, accelerators, tech transfer offices, university translation initiatives, hospitals, research labs and their constituents, with space for incubator members' poster boards (5 poster boards for each tech hub). LSN's network of early-stage global investors will have access to all the key players in one place to learn about the iterative, breakthrough, and transformative technology coming out of the First Coast region...
|
|
Connecticut / Rhode Island
|
|
New York City / New Jersey
|
|
|
|
By Nono Hu, Director of Marketing, LSN
 For those that have been following the summer series thus far, you now have a firm hold on the legal landscape for fundraising as well as the importance of and what constitutes a strong set of marketing materials. In order to organize your outreach and keep track of whom you are sending those materials to, we have found that the proper utilization of cloud infrastructure is the best method to maximize your campaign's efficiency.
Chapter 8 of The Life Science Executive's Fundraising Manifesto, "Leveraging a Cloud Infrastructure to Manage an Outbound Campaign," provides a framework for and describes the key functionality that makes some of today's cloud infrastructure so valuable in any type of outbound campaign. From task management to content delivery and large-scale email campaigns with metrics and tracking, this chapter provides an in-depth look at the value these cloud based products can provide.
Next week we introduce Chapter 9: "
Global Target List-Match Your Firm with Investors That Are a Fit," where the importance of having a global list of relevant investors and the process of creating this list will be discussed.
|
 |
|
|
Created & Produced by
|
 |
|
|
|
